Impact of disease states on the pharmacokinetics and pharmacodynamics of angiotensin-converting enzyme inhibitors.

LeBlanc, Jaclyn M; Dasta, Joseph F; Pruchnicki, Maria C; Schentag, Jerome J

LeBlanc, Jaclyn M; Dasta, Joseph F; Pruchnicki, Maria C; Schentag, Jerome J.

Affiliation

LeBlanc JM; College of Pharmacy, The Ohio State University, Columbus, Ohio, USA

J Clin Pharmacol ; 46(9): 968-80, 2006 Sep.

Article in En | MEDLINE | ID: mdl-16920891

Subject(s)

Angiotensin-Converting Enzyme Inhibitors/pharmacokinetics; Angiotensin-Converting Enzyme Inhibitors/therapeutic use; Hypertension/drug therapy; Aging/drug effects; Angiotensin-Converting Enzyme Inhibitors/pharmacology; Humans; Kidney Transplantation; Liver/drug effects; Liver/physiology

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Angiotensin-Converting Enzyme Inhibitors / Hypertension Limits: Humans Language: En Journal: J Clin Pharmacol Year: 2006 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links